SUEZ unveils new Sievers TOC analyzers for online ultrapure water monitoring

SUEZ – Water Technologies & Solutions announced the launch of two new Total Organic Carbon (TOC) online analyzers, the M500 for life sciences and the M500e for microelectronics markets. Improving on the robust Sievers* portfolio, these new models reduce analysis time by 50 percent and include digital upgrades such as WiFi capabilities, improved data transfer [...]

AutoGen Introduces the NeXTRACT 48

AutoGen introduces a new addition to their instrumentation portfolio, the NeXTRACT 48, a fully automated workflow for extracting viral DNA and RNA. Holliston, MA: Autogen, Inc. is pleased to announce the introduction of their newest fully automated workflow, the NeXTRACT 48. The NeXTRACT 48 is designed for the rapid extraction of viral DNA and/or RNA [...]

Mettler-Toledo International Inc. Announces CEO Transition

- - Patrick Kaltenbach to Become CEO - -- - Olivier Filliol Remains Member of Board of Directors - - COLUMBUS, Ohio -- Mettler-Toledo International Inc. (NYSE: MTD) today announced that Olivier Filliol, after 13 years as CEO, has chosen to step down and the Board of Directors has agreed on a CEO transition. Patrick [...]

ENPICOM and MiLaboratories join forces to power better Repertoire Sequencing data management and analysis workflows

The partnership will allow for a seamless MiXCR integration into the IGX Platform, allowing MiXCR users to leverage its intuitive user interface and unique data management capabilities   ‘s-Hertogenbosch (The Netherlands) and Solana Beach, CA (United States) – ENPICOM BV, an innovative bioinformatics software engineering company, and MiLaboratories LLC, a technology leader in profiling the mammalian [...]

CN Bio and the University of Melbourne collaborate to advance therapies for respiratory complications in recovered COVID-19 patients

CN Bio’s Lung-on-a-Chip technology will enable research into therapies to prevent interstitial lung disease and long-term lung impairment, following SARS-CoV-2 infection Cambridge, UK and Melbourne, Australia: CN Bio, a leading cell culture company, that has developed single and multi-organ microphysiological systems (MPS) to improve the accuracy and efficiency of drug discovery, today announced a collaboration with [...]

CN Bio and the University of Melbourne collaborate to advance therapies for respiratory complications in recovered COVID-19 patients

Sydney, Australia - CN Bio, a leading cell culture company, that has developed single and multi-organ microphysiological systems (MPS) to improve the accuracy and efficiency of drug discovery, today announced a collaboration with the University of Melbourne, focused on respiratory therapies for recovering COVID-19 patients. Harnessing CN Bio’s Organ-on-a-Chip technology, the aim of the research [...]

KTP Grant Expedites Development of Nuclera’s Desktop Gene Printer

CAMBRIDGE, UK – Nuclera, the UK-based biotech company developing desktop gene and protein printing technologies, announces that it has been awarded a Knowledge Transfer Partnership (KTP) grant in support of its work with researchers at the University of Southampton. The research programme at the University of Southampton (Electronics and Computer Science) is being supervised by Professor of Bioelectronics, Hywel Morgan MBE.  [...]

Ultivue Announces New VP Medical Director, VP Manufacturing Operations and Quality

CAMBRIDGE, Mass. -- Ultivue announces the addition of two new executive team members in order to help strengthen its position as a leading assay development solutions provider for multiplex biomarker analysis. Keith Wharton MD PhD has recently joined Ultivue in the role of Vice President, Medical Director, and James (Bud) Drummey has joined as Vice [...]

Dr. Ana K. Stankovic, MD, PhD, Appointed to Fluidigm Board of Directors

SOUTH SAN FRANCISCO, Calif. -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced the appointment of Dr. Ana K. Stankovic, MD, PhD, MSPH, to the company’s Board of Directors. Dr. Stankovic is a seasoned leader with more than 30 years of research and [...]

Singlera Genomics raises $150 million in Series B financing to promote the development and commercialization of early cancer screening products

SAN DIEGO and SHANGHAI -- Singlera Genomics Inc.,. today announced that it raised $150 million in Series B financing. This round of financing was led by the CICC Kai Tak Innovative Biomedicine Fund, and co-led by Detong Capital and Furong Investment. The new group of investors also include Huamei International, Linden Asset Group, Wuxi Capital, FutureX Skyline Capital, Shanghai Free Trade [...]

Access IBO on Knowledge Center